By Professor Marina Pajic

Journal articles

Chou A; Gill AJ; Kang J; Lee C; Sergio M; APGI ; Musgrove L; Morey AL; Grimmond S; Biankin AV; Pajic M, 2014, '9. Cyclin-Dependent kinase inhibitor as a potential novel therapeutic agent for pancreatic cancer', Pathology, 46, pp. S109 - S109, http://dx.doi.org/10.1097/01.pat.0000443699.20071.3b

Kassahn KS; Holmes O; Nones K; Patch AM; Miller DK; Christ AN; Harliwong I; Bruxner TJ; Xu Q; Anderson M; Wood S; Leonard C; Taylor D; Newell F; Song S; Idrisoglu S; Nourse C; Nourbakhsh E; Manning S; Wani S; Steptoe A; Pajic M; Cowley MJ; Pinese M; Chang DK; Gill AJ; Johns AL; Wu J; Wilson PJ; Fink L; Biankin AV; Waddell N; Grimmond SM; Pearson JV, 2013, 'Somatic point mutation calling in low cellularity tumors', Plos One, 8, http://dx.doi.org/10.1371/journal.pone.0074380

Chou A; Waddell N; Cowley MJ; Gill AJ; Chang DK; Patch AM; Nones K; Wu J; Pinese M; Johns AL; Miller DK; Kassahn KS; Nagrial AM; Wasan H; Goldstein D; Toon CW; Chin V; Chantrill L; Humphris J; Mead RS; Rooman I; Samra JS; Pajic M; Musgrove EA; Pearson JV; Morey AL; Grimmond SM; Biankin AV, 2013, 'Clinical and molecular characterization of HER2 amplified-pancreatic cancer', Genome Medicine, 5, pp. 78, http://dx.doi.org/10.1186/gm482

Kemp MW; Molloy TJ; Pajic M; Chapman E, 2013, 'Peer relationships and the biomedical doctorate: A key component of the contemporary learning environment', Journal of Higher Education Policy and Management, 35, pp. 370 - 385, http://dx.doi.org/10.1080/1360080X.2013.812055

Chin VT; Nagrial A; Chantrill LA; Chang DK; Chou A; Humprhis J; Cowley M; Wu J; DiPetro R; Watson C; Spielman C; Steinmann A; Pinese M; Pettitt J; Johns A; Waddell N; Grimmond S; Timpson P; Biankin AV; Pajic M, 2013, 'From functional genomics to precision medicine: The therapeutic potential of targeting ROCK signaling in pancreatic cancer.', Journal of Clinical Oncology, 31, pp. e15029 - e15029, http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e15029

Kemp MW; Pajic M; Molloy TJ; Chapman E, 2013, 'Perceived assessment requirements in the contemporary biomedical doctorate: A case-study from a research intensive australian university', International Journal of Doctoral Studies, 8, pp. 105 - 120, http://dx.doi.org/10.28945/1893

Alexandrov LB; Nik-Zainal S; Wedge DC; Aparicio SAJR; Behjati S; Biankin AV; Bignell GR; Bolli N; Borg A; Børresen-Dale AL; Boyault S; Burkhardt B; Butler AP; Caldas C; Davies HR; Desmedt C; Eils R; Eyfjörd JE; Foekens JA; Greaves M; Hosoda F; Hutter B; Ilicic T; Imbeaud S; Imielinsk M; Jäger N; Jones DTW; Jonas D; Knappskog S; Koo M; Lakhani SR; López-Otín C; Martin S; Munshi NC; Nakamura H; Northcott PA; Pajic M; Papaemmanuil E; Paradiso A; Pearson JV; Puente XS; Raine K; Ramakrishna M; Richardson AL; Richter J; Rosenstiel P; Schlesner M; Schumacher TN; Span PN; Teague JW; Totoki Y; Tutt ANJ; Valdés-Mas R; Van Buuren MM; Van 'T Veer L; Vincent-Salomon A; Waddell N; Yates LR; Zucman-Rossi J; Andrew Futreal P; McDermott U; Lichter P; Meyerson M; Grimmond SM; Siebert R; Campo E; Shibata T; Pfister SM; Campbell PJ; Stratton MR, 2013, 'Signatures of mutational processes in human cancer', Nature, 500, pp. 415 - 421, http://dx.doi.org/10.1038/nature12477

Alexandrov LB; Nik-Zainal S; Wedge DC; Aparicio SAJR; Behjati S; Biankin AV; Bignell GR; Bolli N; Borg A; Børresen-Dale A-L; Boyault S; Burkhardt B; Butler AP; Caldas C; Davies HR; Desmedt C; Eils R; Eyfjörd JE; Foekens JA; Greaves M; Hosoda F; Hutter B; Ilicic T; Imbeaud S; Imielinski M; Jäger N; Jones DTW; Knappskog S; Kool M; Lakhani SR; López-Otín C; Martin S; Munshi NC; Nakamura H; Northcott PA; Pajic M; Papaemmanuil E; Paradiso A; Pearson JV; Puente XS; Raine K; Ramakrishna M; Richardson AL; Richter J; Rosenstiel P; Schlesner M; Schumacher TN; Span PN; Teague JW; Totoki Y; Tutt ANJ; Valdés-Mas R; Van Buuren MM; Van 'T Veer L; Vincent-Salomon A; Waddell N; Yates LR; Zucman-Rossi J; Futreal PA; McDermott U; Lichter P; Meyerson M; Grimmond SM; Siebert R; Campo E; Shibata T; Pfister SM; Campbell PJ; Stratton MR, 2013, 'Erratum: Signatures of mutational processes in human cancer', Nature, 502, pp. 258 - 258, http://dx.doi.org/10.1038/nature12666

Chang DK; Jamieson N; Johns A; Scarlett CJ; Pajic M; Biankin AV; et A, 2013, 'Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater', Journal of Clinical Oncology, 31, pp. 1348 - 1356, http://dx.doi.org/10.1200/JCO.2012.46.8868

Harliwong I; Gudkov AV; De Ridder J; Burkhart CA; Knosel T; Rummele P; Pajic M; Sartorelli AC; van der Weyden L, 2012, 'Impact of intertumoral heterogeneity on predicting chemotheraphy response of BRCA1-deficient mammary tumors', Cancer Research, 72, pp. 2350 - 2361, http://dx.doi.org/10.1158/0008-5472.CAN-11-4201

Biankin AV; Waddell NJ; Kassahn KS; Gingras M-C; Muthuswamy L; Johns AL; Miller DK; Wilson PJ; Patchett A-M; Wu J; Chang DK; Cowley MJ; Gardiner BB; Song S; Harliwong I; Idrisoglu S; Nourse C; Nourbakhsh E; Manning S; Wani S; Gongora MM; Pajic M; Scarlett CJ; Gill AJ; Pinho AV; Rooman I; Anderson ML; Holmes O; Leonard C; Taylor DF; Wood SA; Xu Q; Nones K; Fink JL; Christ A; Bruxner T; Cloonan N; Kolle G; Newell F; Pinese M; Mead RS; Humphris J; Kaplan W; Jones M; Colvin EK; Nagrial AM; Humphreys ES; Chou A; Chin VT; Chantrill LA; Mawson A; Samra JS; Kench JG; Lovell JA; Daly RJ; Merrett ND; Toon C; Epari K; Nguyen NQ; Barbour A; Zeps N; Kakkar N; Zhao F; Wu YQ; Wang MJ; Muzny DM; Fisher WE; Brunicardi FC; Hodges SE; Reid JG; Drummond J; Chang K; Han Y; Lewis LR; Dinh H; Buhay CJ; Beck T; Timms L; Sam M; Begley K; Brown A; Pai D; Panchal A; Buchner N; De Borja R; Denroche RE; Yung CK; Serra S; Onetto N; Mukhopadhyay D; Tsao M; Shaw PA; Petersen G; Gallinger S; Hruban R; Maitra A; Iacobuzio-donahue CA; Schulick RD; Wolfgang ; Morgan RA; Lawlor RT; Capelli P; Corbo V; Scardoni M; Tortora G; Tempero MA; Mann KM; Jenkins NA; Perez-Mancera PA; Adams DJ; Largaespada DA; Wessels LFA; Rust AG; Stein LD; Tuveson DA; Copeland NG; Musgrove EA; Scarpa A; Eshleman JR; Hudson TJ; Sutherland RL; Wheeler DA; Pearson JV; McPherson JD; Gibbs RA; Grimmond SM, 2012, 'Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes', Nature, 491, pp. 399 - 405, http://dx.doi.org/10.1038/nature11547

Song S; Nones K; Miller DK; Harliwong I; Pinese M; Kassahn KS; Pajic M; Gill A; Johns A; Anderson ML; Holmes O; Leonard C; Taylor DF; Wood SA; Xu Q; Newell FS; Cowley MJ; Wu J; Wilson PJ; Fink L; Biankin AV; Waddell NJ; Grimmond S; Pearson JV, 2012, 'qpure: A tool to estimate tumor cellularity from genome-wide single-nucleotide polymorphism profiles', PLoS ONE, 7, pp. e45835, http://dx.doi.org/10.1371/journal.pone.0045835

Perez-Mancera P; Rust AG; van der Weyden L; Kristiansen GO; Kristiansen GO; Li A; Sarver AL; Silverstein KAT; Grutzmann R; Aust DE; Rummele P; Knosel T; Herd C; Stemple D; Kettleborough R; Brosnan JA; Li A; Richard GM; Knight S; Yu J; Stegeman S; Collier LS; Ten Hoeve JJ; De Ridder J; Klein A; Goggins M; Hruban R; Chang D; Biankin AV; Pinese M; Grimmond S; Wessels L; Wood S; Iacobuzio-donahue CA; Pilarsky CP; Largaespada DA; Adams DJ; Tuveson DA; Rooman I; Pavey D; Cosman P; Nagrial A; Merrett N; asghari R; Cowley M; Daly R; Musgrove E; Pajic M; Wu J; Chang D; Chantrill L; Sutherland R; Gill A; Mawson A; Chou A; Kaplan W; Toon CCW; Johns A, 2012, 'The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma', Nature, 486, pp. 266 - 270, http://dx.doi.org/10.1038/nature11114

Chang DK; Colvin EK; Scarlett CJ; Pajic M; Pinese M; Gill AJ; Musgrove EA; Sutherland R; Kench J; Biankin AV, 2011, 'A molecular prognostic nomogram for resectable pancreatic cancer', JOURNAL OF CLINICAL ONCOLOGY, 29, http://dx.doi.org/10.1200/jco.2011.29.4_suppl.154

Chang DK; Johns A; Scarlett CJ; Pajic M; Chou A; Toon C; Samra JS; Sutherland R; Gill AJ; Biankin AV, 2011, 'Molecular pathologic phenotypes and outcome in adenocarcinoma of the ampulla of Vater', JOURNAL OF CLINICAL ONCOLOGY, 29, http://dx.doi.org/10.1200/jco.2011.29.4_suppl.196

Chang DK; Colvin EK; Scarlett CJ; Pajic M; Pinese M; Gill AJ; Musgrove EA; Sutherland R; Kench J; Biankin AV; New South Wales Pancreatic Cancer Network , 2011, 'A molecular prognostic nomogram for resectable pancreatic cancer.', J Clin Oncol, 29, pp. 154, http://www.ncbi.nlm.nih.gov/pubmed/27985628

Chang DK; Johns A; Scarlett CJ; Pajic M; Chou A; Toon C; Samra JS; Sutherland R; Gill AJ; Biankin AV; New South Wales Pancreatic Cancer Network , 2011, 'Molecular pathologic phenotypes and outcome in adenocarcinoma of the ampulla of Vater.', J Clin Oncol, 29, pp. 196, http://www.ncbi.nlm.nih.gov/pubmed/27985359

Scarlett CJ; Chang DK; Stoddart ES; Colvin EK; Mawson A; Jones MD; Tobelmann PE; Pajic M; Daly RJ; Biankin AV, 2010, 'High S100A2 Calcium-Binding Protein Expression Defines a Metastatic Phenotype in Pancreatic Cancer', PANCREAS, 39, pp. 1345 - 1346, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000282946600205&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chang D; Johns A; Scarlett C; Pajic M; Chou A; Jones M; Samra J; Henshall S; Musgrove E; Sutherland R; Gill A; Biankin A, 2010, 'Histology and Molecular Pathology Define Clinically Relevant Phenotypes in Carcinoma of the Ampulla of Vater', PANCREAS, 39, pp. 1313 - 1314, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000282946600067&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pajic M; Kersbergen A; Van Diepen F; Pfauth A; Jonkers J; Borst P; Rottenberg S, 2010, 'Tumor-initiating cells are not enriched in cisplatin-surviving BRCA1;p53-deficient mammary tumor cells in vivo', Cell Cycle, 9, pp. 3804 - 3815, http://dx.doi.org/10.4161/cc.9.18.13002

Zander SAL; Kersbergen A; Van Der Burg E; De Water N; Van Tellingen O; Gunnarsdottir S; Jaspers JE; Pajic M; Nygren AOH; Jonkers J; Borst P; Rottenberg S, 2010, 'Sensitivity and acquired resistance of BRCA1;p53-deficient mouse mammary tumors to the topoisomerase I inhibitor topotecan', Cancer Research, 70, pp. 1700 - 1710, http://dx.doi.org/10.1158/0008-5472.CAN-09-3367

Rottenberg S; Pajic M; Jonkers J, 2010, 'Studying drug resistance using genetically engineered mouse models for breast cancer.', Methods in Molecular Biology Clifton N J, 596, pp. 33 - 45, http://dx.doi.org/10.1007/978-1-60761-416-6_3

Borst P; Rottenberg S; Jonkers J; Zander S; Pajic M; Jaspers J, 2010, 'The contribution of ABC transporters to drug resistance in a realistic mouse mammary tumor model', Cancer Genetics and Cytogenetics, 203, pp. 64 - 64, http://dx.doi.org/10.1016/j.cancergencyto.2010.07.044

Pajic M; Iyer JK; Kersbergen A; Van Der Burg E; Nygren AOH; Jonkers J; Borst P; Rottenberg S, 2009, 'Moderate increase in Mdr1a/1b expression causes in vivo resistance to doxorubicin in a mouse model for hereditary breast cancer', Cancer Research, 69, pp. 6396 - 6404, http://dx.doi.org/10.1158/0008-5472.CAN-09-0041

Rottenberg S; Nygren AOH; Pajic M; Van Leeuwen FWB; Van Der Heijden I; Van Wetering KD; Liu X; De Visser KE; Gilhuijs KG; Van Tellingen O; Schouten JP; Jonkers J; Borst P, 2007, 'Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer', Proceedings of the National Academy of Sciences of the United States of America, 104, pp. 12117 - 12122, http://dx.doi.org/10.1073/pnas.0702955104

Chung S; Wei A; Connor DE; Webb GC; Molloy TJ; Pajic M; Diwan AD, 2007, 'Nucleus pulposus cellular longevity by telomerase gene therapy', Spine, 32, pp. 1188 - 1196

Pajic M; Norris MD; Cohn RJ; Haber M, 2005, 'The role of the multidrug resistance-associated protein 1 gene in neuroblastoma biology and clinical outcome', Cancer Letters, 228, pp. 241 - 246

Pajic M; Bebawy M; Hoskins JM; Roufogalis BD; Rivory LP, 2004, 'Effect of short-term morphine exposure on P-glycoprotein expression and activity in cancer cell lines', Oncology Reports, 11, pp. 1091 - 1095, http://dx.doi.org/10.3892/or.11.5.1091

Ivanovic V; Filipovic V; Pajic M; Santini A, 1987, 'Tertiary dentine formation in dogs' teeth in response to lining materials.', J Dent, 15, pp. 85 - 87, http://dx.doi.org/10.1016/0300-5712(87)90006-6

Conference Papers

Fajardo DC; Moore CL; Porazinski S; McLean B; Borbilas E; Kothari V; Machajewski T; Rock F; Turner SM; Pajic M, 2023, '1467 Selective targeting of integrins αVβ8 and αVβ1 within the dynamic ecosystem of pancreatic cancer to improve the overall anti-tumor response', in Regular and Young Investigator Award Abstracts, BMJ Publishing Group Ltd, pp. A1631 - A1631, presented at SITC 38th Annual Meeting (SITC 2023) Abstracts, http://dx.doi.org/10.1136/jitc-2023-sitc2023.1467

Chou A; Steinmann A; Froio D; Drury A; Wohl D; Chin V; Nagrial A; Gill A; Pajic M, 2016, 'Combination of CDK4/6 inhibitor PD-0332991 with standard chemotherapy is synergistic in RB high pancreatic cancer', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, pp. S182 - S182, http://dx.doi.org/10.1016/S0959-8049(16)61645-3

Chin VT; Nagrial A; Chantrill LA; Sjoquist KM; O'Connor C; Pajic M; Blankin AV; Yip D, 2014, 'Targeted therapies in the treatment of advanced pancreatic adenocarcinoma (PC): A systematic review and meta-analysis of randomized trials', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at 50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), IL, Chicago, 30 May 2014 - 03 June 2014, http://dx.doi.org/10.1200/jco.2014.32.15_suppl.e15209

Nagrial A; Chin V; Steinmann A; Chou A; Grimmond S; Horvath L; Pajic M; Biankin A, 2014, 'GENOMIC CLASSIFIER FOR PANCREATIC DUCTAL ADENOCARCINOMA THERAPEUTIC RESPONSE', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 44 - 44, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339716500009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chin V; Nagrial A; Chantrill L; Sjoquist K; O'Connor C; Pajic M; Biankin A; Yip D, 2014, 'PHARMACOLOGIC INTERVENTIONS FOR ADVANCED PANCREATIC CANCER (PC) - A META-ANALYSIS COMPARING GEMCITABINE ALONE (G) VERSUS GEMCITABINE COMBINATIONS (GCs)', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 48 - 48, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339716500014&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pajic M; Graham PH; Millar EKA; O'Toole SA; Molloy TJ, 2013, 'MicroRNA-regulated pathways of radiotherapy sensitivity and resistance in breast cancer', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, NETHERLANDS, Amsterdam, pp. S232 - S232, presented at European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, NETHERLANDS, Amsterdam, 27 September 2013 - 01 October 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326843601304&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chang DK; Pinese M; Scarlett CJ; Pajic M; Colvin EK; Johns AL; Wu J; Cowley MJ; Humphris JL; Chou A; Nguyen NQ; Nagrial AM; Chantrill L; Chin VT; Musgrove EA; Altekruse S; Gill AJ; Kench JG; Biankin AV, 2013, 'A molecular pre-operative prognostic nomogram for resectable pancreatic cancer', in Cancer Research, American Association for Cancer Research, Washington, DC, presented at 104th Annual Meeting of the American-Association-for-Cancer-Research (AACR), Washington, DC, 06 April 2013 - 10 April 2013, http://dx.doi.org/10.1158/1538-7445.AM2013-1156

Chang DK; Chou A; Nguyen NQ; Nagrial AM; Chantrill LA; Chin VT; Musgrove EA; Sutherland RL; Gill AJ; Altekruse S; Kench JG; Scarlett CJ; Biankin AV; Pinese M; Pajic M; Colvin EK; Johns AL; Humphris JL; Wu J; Cowley MJ, 2012, 'Abstract B64: A molecular preoperative prognostic nomogram for resectable pancreatic cancer.', in Tumor Biology, American Association for Cancer Research, pp. B64 - B64, presented at Abstracts: AACR Special Conference on Pancreatic Cancer: Progress and Challenges; June 18-21, 2012; Lake Tahoe, NV, http://dx.doi.org/10.1158/1538-7445.panca2012-b64

Molloy T; Pajic M; Holzhauser S; Graham P; Millar EKA; Sutherland RL, 2012, 'Identifying Putative MiRNAs Mediators of Radiotherapy Resistance in Breast Cancer', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, SPAIN, Barcelona, pp. S270 - S270, presented at 22nd Biennial Congress of the European-Association-for-Cancer-Research, SPAIN, Barcelona, 07 July 2012 - 10 July 2012, http://dx.doi.org/10.1016/S0959-8049(12)71723-9

Rottenberg S; Pajic M; Kersbergen A; Banishki N; Xu G; Jonkers J; Borst P, 2010, 'Abstract A14: Lack of tumor eradication of chemotherapy-sensitive BRCA1;p53-deficient mouse mammary tumors', in Clinical Cancer Research, American Association for Cancer Research (AACR), pp. A14 - A14, http://dx.doi.org/10.1158/1078-0432.tcme10-a14

Borst P; Rottenberg S; Jonkers J; Zander S; Pajic M; Jaspers J, 2010, 'Abstract PL6-1: Resistance to targeted therapies in a realistic mouse breast cancer model', in Clinical Cancer Research, American Association for Cancer Research (AACR), http://dx.doi.org/10.1158/1078-0432.tcme10-pl6-1

Burkhart CA; Watt F; Pajic M; Murray J; Xue C; Flemming C; Smith J; Marshall GM; Haber M; Norris MD; Gudkov AV, 2006, 'Selective Sensitization of murine tumors to chemotherapy by a novel class of non-toxic small molecule inhibitors of MRP1', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000454606201252&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Posters

Chin V; Nagrial A; Chang D; Chantrill L; Cowley M; Wu J; Spielman C; Steinmann A; Pinese M; Pettitt J; Johns A; Gill A; Timpson P; Biankin A; Pajic M, 2013, 'From function genomics to precision medicine: the therapeutic potential of targeting rock signalling in pancreatic cancer', Chicago, IL, Vol. 9, pp. 53 - 53, presented at ASCO Annual Meeting, Chicago, IL, 31 May 2013 - 04 June 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000329462300024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Presentations

Pinho AV; Grimont A; Cowley MJ; Augereau C; Mawson A; Giry-Laterriere M; Van den Steen G; Waddell N; Pajic M; Sempoux C; Wu J; Grimmond SM; Biankin AV; Lemaigre FP; Jacquemin P; Rooman I, 2014, 'SOX9 regulates EGFR/ERBB signaling in pancreatic cancer', presented at 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), CA, San Diego, 05 April 2014 - 09 April 2014, http://dx.doi.org/10.1158/1538-7445.AM2014-LB-73

Chou A; Chin VT; Nagrial AM; Gill AJ; Timpson P; Chang DK; Waddell N; Wu J; Grimmond SM; Biankin AV; Pajic M, 2014, 'From functional genomics to precision medicine: Using well annotated models to define personalised treatment strategies for pancreatic cancer', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000341276000017&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Humphris J; Tao J; Chang D; Johns A; Cowley MJ; Pajic M; Jones M; Simpson S; Mead S; Biankin A, 2012, 'Somatic mutations in pancreatic ductal adenocarcinoma using amplicon sequencing from formalin fixed paraffin embedded tissue', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308642600042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Abstracts

Tyma V; Liew Y-F; Tran A; Howell A; Ritchie S; Atlas AAPCM; Cox T; Pajic M; Herrmann D; Pereira B; Timpson P; Gordon K, 2024, 'Identifying and targeting FOLFIRINOX resistance mechanisms to improve outcomes in pancreatic cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, MA, Boston, Vol. 84, presented at AACR Special Conference in Cancer Research: Advances in Pancreatic Cancer Research, MA, Boston, 15 September 2024 - 18 September 2024, http://dx.doi.org/10.1158/1538-7445.PANCREATIC24-A067

Pajic M; McLean B; Fajardo DC; Porazinski S; Upton DH; Schuhmacher D; Istadi A; Cox T; Timpson P; Wilcock DJ; Anderson KJ; Mason H; Guisot NE; Jones CD; Phillips C; Armer R, 2024, 'Combining zelasudil, a small molecule ROCK2 inhibitor, with chemotherapy or immunotherapy improves response in preclinical models of pancreatic cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, CA, San Diego, Vol. 84, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), CA, San Diego, 05 April 2024 - 10 April 2024, http://dx.doi.org/10.1158/1538-7445.AM2024-720

Upton D; Fajardo DC; Omari S; Porazinski S; McLean B; Schuhmacher D; Istadi A; Kothari V; Finkelstein D; Machajewski T; Rock F; Turner S; Pajic M, 2024, 'Selective targeting of integrins αVβ8 and αVβ1 within the dynamic ecosystem of pancreatic cancer to improve the overall anti-tumor response', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, CA, San Diego, Vol. 84, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), CA, San Diego, 05 April 2024 - 10 April 2024, http://dx.doi.org/10.1158/1538-7445.AM2024-6575

Pitiyarachchi O; Lin FP; Spooner A; Sharbeen G; Barker HP; Thornton K; Collignon E; Ballinger ML; Thomas DM; Magenau A; Porazinski S; Raina A; Sjoquist KM; Chantrill LA; Gebski V; Sowmya A; Timpson P; Pajic M; Goldstein D; Phillips PA, 2024, '1513P Impact of symptom and functional burden on survival in pancreatic ductal adenocarcinoma (PDAC)', in Annals of Oncology, Elsevier BV, Vol. 35, pp. S925 - S925, http://dx.doi.org/10.1016/j.annonc.2024.08.1576

Murphy KJ; Reed DA; Chambers CR; Channon LM; Pajic M; Herrmann D; Timpson P, 2023, 'Anti-fibrotic FAK 'priming' to improve contemporary chemotherapy in pancreatic cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, MA, Boston, Vol. 84, presented at AACR Special Conference - Pancreatic Cancer, MA, Boston, 27 September 2023 - 30 September 2023, http://dx.doi.org/10.1158/1538-7445.PANCA2023-B037

Back to profile page